Frédéric Rondu - Concepedia

Author

Frédéric Rondu

Also Known As

F Rondu, Frédéric Rondu, Rondu, F.

Publications

237

Citations

H-Index

Concepts

All Affiliations

Frédéric Rondu is an author at Université Toulouse III - Paul Sabatier specializing in natural sciences, drug discovery, and molecular pharmacology.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	67
2	Natural Sciences	1	1	67
3	Biochemistry	1	1	67
4	Pharmacology	1	1	67
5	Drug Discovery	1	1	67

Frédéric Rondu

Publications

230

Citations

H-Index

Page 1

	Year	Citations
Design and Synthesis of Imidazoline Derivatives Active on Glucose Homeostasis in a Rat Model of Type II Diabetes. 1. Synthesis and Biological Activities of <i>N</i>-Benzyl-<i>N</i> ‘-(arylalkyl)-2-(4‘,5‘-dihydro-1‘<i>H</i>-imidazol-2‘-yl)piperazines Frédéric Rondu, Gae͏̈lle Le Bihan, Xuan Wang, Journal of Medicinal Chemistry	1997	107
Design and Synthesis of Imidazoline Derivatives Active on Glucose Homeostasis in a Rat Model of Type II Diabetes. 2. Syntheses and Biological Activities of 1,4-Dialkyl-, 1,4-Dibenzyl, and 1-Benzyl-4-alkyl-2-(4‘,5‘-dihydro-1‘<i>H</i>- imidazol-2‘-yl)piperazines and Isosteric Analogues of Imidazoline Gae͏̈lle Le Bihan, Frédéric Rondu, Agnès Pelé‐Tounian, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryGlucose ToleranceHeterocyclicBiochemistry	1999	67
Effect of S-21663 (PMS 812), an imidazoline derivative, on glucose tolerance and insulin secretion in a rat model of type II diabetes. Xuan Wang, Frédéric Rondu, Azzdine Lamouri, Journal of Pharmacology and Experimental Therapeutics	1996	30
Potent antihyperglycaemic property of a new imidazoline derivative S‐22068 (PMS 847) in a rat model of NIDDM Agnès Pelé‐Tounian, Xuan Wang, Frédéric Rondu, British Journal of Pharmacology	1998	26

Page 1